Abstract:Abstract Background The spread of the novel coronavirus SARS-CoV-2 and the guidance from authorities for social distancing and media reporting lead to significant uncertainty in Germany. Concerns have been expressed regarding the underdiagnosing of harmful diseases. We explored the rates of emergency presentations for acute coronary syndrome (ACS) and acute cerebrovascular events (ACVE) before and after spread of SARS-CoV-2. Methods We analyzed all-cause visits at a tertiary university emergency department and admissions for ACS and ACVE before (calendar weeks 1–9, 2020) and after (calendar weeks 10–16, 2020) the first coronavirus disease (COVID-19) case in the region of the Saarland, Germany. The data were compared with the same period of the previous year. Results In 2020 an average of 346 patients per week presented at the emergency department whereas in 2019 an average of 400 patients presented up to calendar week 16 ( p = 0.018; whole year 2019 = 395 patients per week). After the first COVID-19 diagnosis in the region, emergency department visit volume decreased by 30% compared with the same period in 2019 ( p = 0.0012). Admissions due to ACS decreased by 41% ( p = 0.0023 for all; Δ − 71% ( p = 0.007) for unstable angina, Δ − 25% ( p = 0.42) for myocardial infarction with ST-elevation and Δ − 17% ( p = 0.28) without ST-elevation) compared with the same period in 2019 and decreased from 142 patients in calendar weeks 1–9 to 62 patients in calendar weeks 10–16. ACVE decreased numerically by 20% [ p = 0.25 for all; transient ischemic attack: Δ − 32% ( p = 0.18), ischemic stroke: Δ − 23% ( p = 0.48), intracerebral haemorrhage: Δ + 57% ( p = 0.4)]. There was no significant change in ACVE per week ( p = 0.7) comparing calendar weeks 1–9 (213 patients) and weeks 10–16 (147 patients). Testing of 3756 samples was performed to detect 58 SARS-CoV-2 positive patients (prevalence 1,54%, thereof one patient with myocardial and two with cerebral ischemia) up to calendar week 16 in 2020. Conclusions The COVID-19 pandemic was associated with a significant decrease in all-cause admission and admissions due to cardiovascular events in the emergency department. Regarding acute cerebrovascular events there was a numerical decrease but no significant difference.

Deaths related to pulmonary embolism and cardiovascular events before and during the 2020 COVID-19 pandemic: An epidemiological analysis of data from an Italian high-risk area

COVID-19 patients with acute pulmonary embolism have a higher mortality risk: systematic review and meta-analysis based on Italian cohorts.

Prevalence of Acute Pulmonary Embolism at Autopsy in Patients with COVID-19

[Incidence of Acute Pulmonary Embolism in Hospitalized COVID-19 Italian Patients. A Pooled Meta-Analysis].

P279 MORTALITY RISK DUE TO ACUTE PULMONARY EMBOLISM IN COVID–19 PATIENTS: META–ANALYSIS BASED ON ITALIAN COHORTS

Abstract 11754: Trends in Cardiovascular Mortality Before and During the COVID-19 Pandemic

Excess of Heart Failure-Related Deaths During the 2020 COVID-19 Pandemic in Unites States

Decline of Admission for Acute Coronary Syndromes and Acute Cardiovascular Conditions During COVID-19 Pandemic in Veneto Region.

Contemporary Trends in Mortality Related to High-Risk Pulmonary Embolism in US from 1999 to 2019.

Clinical outcomes for patients with cardiovascular diseases before, during, and after the COVID19 pandemic. A pooled analysis of 600.000 patients.

Risk Factors for Pulmonary Embolism in Individuals Infected with SARS-CoV2—A Single-Centre Retrospective Study

Persistent increase of cardiovascular and cerebrovascular events in COVID-19 patients: a 3-year population-based analysis

Deaths related to post-COVID in Italy: a national study based on death certificates

Trends in Pulmonary Embolism Deaths among Young Adults Aged 25 to 44 Years in the United States, 1999 to 2019.

Association between pulmonary embolism and COVID-19 disease

Retrospective analysis of venous thromboembolism, arterial thromboembolism, and microthrombosis incidence at a single center during the COVID-19 pandemic

Impact of the COVID-19 pandemic on in-hospital mortality in cardiovascular disease: a meta-analysis

Thromboembolic Disease and COVID-19: Experience of a University and Emergency Hospital During the Pandemic

Pulmonary Embolism in Patients with COVID-19: Comparison between Different Care Settings

Impact of SARS-CoV-2 Outbreak on Emergency Department Presentation and Prognosis of Patients with Acute Myocardial Infarction: A Systematic Review and Updated Meta-Analysis

Decline of emergency admissions for cardiovascular and cerebrovascular events after the outbreak of COVID-19